NCT03906825View on ClinicalTrials.gov

Effect of CEAG on Inflammation and Endothelial Function

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

May 17, 2018

Primary Completion Date

August 13, 2018

Study Completion Date

August 13, 2018

Conditions
InflammationEndothelial Dysfunction
Interventions
DIETARY_SUPPLEMENT

CEAG

Curcuminoids, EPA (OMEGA-3), Astaxanthin, GLA

DIETARY_SUPPLEMENT

placebo

placebo

Trial Locations (1)

90502

Lundquist Institute for Biomedical Innovation at Harbor UCLA Medical Center, Torrance

All Listed Sponsors
lead

Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center

OTHER

NCT03906825 - Effect of CEAG on Inflammation and Endothelial Function | Biotech Hunter | Biotech Hunter